AMGN - AMGEN INC
377
-8.700 -2.308%
Share volume: 2,708,247
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$385.70
-8.70
-0.02%
Summary score
57%
Profitability
71%
Dept financing
43%
Liquidity
30%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
2.97%
Return on sales
27.71%
Return on invested capital
0%
Total debt ratio
93.27%
Debt ratio change over timeo
14.34%
Current Ratio
1.67%
Quick Ratio
1.33%
Cash Position Ratio
0.77%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
3.27%
Return on sales
24.35%
Return on invested capital
0%
Total debt ratio
91.09%
Debt ratio change over timeo
0%
Current Ratio
1.22%
Quick Ratio
0.94%
Cash Position Ratio
0.39%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.39%
Return on sales
27.57%
Return on invested capital
0%
Total debt ratio
90.44%
Debt ratio change over time
0%
Current Ratio
1.14%
Quick Ratio
0.9%
Cash Position Ratio
0.36%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-48.13%
Return on sales
524.6%
Return on invested capital
0%
Total debt ratio
1434.39%
Debt ratio change over time
14.34%
Current Ratio
21.4%
Quick Ratio
16.06%
Cash Position Ratio
6.9%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMGN | GILD | BIIB | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 5.97% | 8.91% | 6.4% |
| Return on assets | 2.97% | 3.34% | 2.04% | 6.32% |
| Return on sales | 27.71% | 27.82% | 21.49% | -23.43% |
| Return on invested capital | 0% | 3.51% | 10.25% | -29.64% |
| Profitability | 37% | 64% | 77% | 43% |
| Total debt ratio | 93.27% | 65.75% | 43.64% | 14.04% |
| Debt ratio change over time | 14.34% | 187.33% | 9.75% | -1% |
| Dept financing | 27% | 43% | 13% | 4% |
| Current Ratio | 1.22% | 1.42% | 2.33% | 0% |
| Quick Ratio | 0.94% | 1.27% | 1.72% | 0% |
| Cash Position Ratio | 0.39% | 0.58% | 0.86% | 0% |
| Liquididy | 13% | 10% | 15% | 75% |
| Short-term ratios | AMGN | GILD | BIIB | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 3.27% | 4.7% | 1.36% | 0% |
| Return on sales | 24.35% | 34.09% | 15.11% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 85% | 50% | 18% | 0% |
| Total debt ratio | 91.09% | 63.87% | 38.21% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 18% | 10% | 0% |
| Current Ratio | 1.22% | 1.42% | 2.33% | 0% |
| Quick Ratio | 0.94% | 1.27% | 1.72% | 0% |
| Cash Position Ratio | 0.39% | 0.58% | 0.86% | 0% |
| Liquididy | 38% | 51% | 75% | 0% |